| Address: | 121 River St, Hoboken, NJ 07030, USA |
|---|---|
| Postal code: | 07030 |
| Phone: | (201) 604-1130 |
| Website: | http://www.wilateusa.com/index.php?option=com_content&view=article&id=61&Itemid=85 |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Wilate, use the form below and your opinion, advice or comment will appear in this space.
P: 201-604-1130. Customer Service. For general questions about wilate von Willebrand Factor/Coagulation Factor VIII Complex (Human), reconstitution, product support, or this site, please contact Octapharma Customer Service.
WILATE^® is a human plasma-derived, sterile, purified, double virus inactivated von Willebrand Factor (VWF)/coagulation Factor VIII (FVIII) complex initially approved by the WIL-0223. Octapharma USA, Inc.• 121 River Street, Suite 1201• Hoboken, NJ 07030 •. 201-604-1130 • www.octapharmausa.com.
For more information call (201) 604-1130 or visit www.octapharma.com. Octapharma AG announced that it has received orphan drug exclusivity approval for wilate (double virus inactivated von Willebrand Factor/Coagulation Factor VIII concentrate [human]) for the treatment of spontaneous or...
Octapharma USA, Inc. 121 River Street, Suite 1201 Hoboken, NJ 07030 (201) 604-1130. Wilate Generic name: antihemophilic factor/von willebrand factor Drug class: miscellaneous coagulation modifiers. Users were asked how effective they found the medicine while considering positive/adverse...
Fax: (201) 604-1131. usmedicalaffairs@octapharma.com. Bleeding disorders. WILATE.
Fax: (201) 604-1131. usmedicalaffairs@octapharma.com. Bleeding disorders. WILATE.
Fax: (201) 604-1131. usmedicalaffairs@octapharma.com. WILATE. Bleeding disorders.
Wilate drug & pharmaceuticals active ingredients names and forms, pharmaceutical companies. Wilate pharmaceutical active ingredients containing related brand and generic drugs: Active ingredient is the part of the drug or medicine which is biologically active.
CONTACT: Contact: Corinne Landolt, Tel: +1-201-604-1122,corinne.landolt@octapharma.com. Related articles. Octapharma Receives Orphan Drug Exclusivity Approval For Wilate(R)- The First Replacement Therapy Developed Specifically For Von Willebrand Disease.
Wilate should be reconstituted to the same volume and in the same diluent as for bolus infusion, and administered using an infusion pump suitable for this volume. Reconstitution: Before reconstitution, allow the vial of Wilate and water for injections to reach a temperature % 201-500mg. 1. 100.0%.